Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3747325 | 1.00 | — | — | |
| SCHEMBL31094592 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL5552968 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL1546235 | 1.00 | — | — | |
| SCHEMBL17848839 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL3742815 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL23869543 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL3742821 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL3684198 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL27871715 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116925342-A | Preparation method of ultrahigh molecular weight nylon 12 with low end group content | 万华化学集团股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-112142683-B | Aza-eleven-membered ring compound, preparation method and application thereof, and medicine containing compound | 成都大学 | 2022-05-24 | — | — | CN | claimed |
| CN-107001367-A | 2- [ bis (4-fluorophenyl) methyl ] -2, 7-diazaspiro [4.5] decan-10-one derivatives and related compounds as inhibitors of human Dopamine Active Transporter (DAT) protein for the treatment of e.g. Attention Deficit Disorder (ADD) | 克罗诺斯治疗有限公司 | 2017-08-01 | — | — | CN | claimed |
| CN-104844656-A | Non-sulfur and non-phosphorus organic molybdenum compound and preparation method and application thereof | UNIV SHANGHAI JIAOTONG | 2015-08-19 | — | — | CN | claimed |
| US-5594142-A | USING SOLVENT MIXTURE AND BASIC CATALYST | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-01-14 | — | — | US | claimed |
| WO-2024097805-A1 | MIXED LINEAGE KINASE DOMAIN LIKE PSEUDOKINASE (MLKL) ACTIVATORS | TRUSTEES OF TUFTS COLLEGE (US) | 2024-05-10 | — | — | WO | disclosed |
| US-20240018111-A1 | ALPHA, BETA UNSATURATED METHACRYLIC ESTERS WITH ANTI-INFLAMMATORY PROPERTIES | SITRYX THERAPEUTICS LIMITED (GB) | 2024-01-18 | — | — | US | disclosed |
| CN-116925342-A | Preparation method of ultrahigh molecular weight nylon 12 with low end group content | 万华化学集团股份有限公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20230219907-A1 | CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES | SITRYX THERAPEUTICS LIMITED (GB) | 2023-07-13 | — | — | US | disclosed |
| WO-2023009817-A2 | PHOSPHATE PRODRUGS OF CANNABINOIDS | EMORY UNIVERSITY (US) | 2023-02-02 | — | — | WO | disclosed |
| CN-112142683-B | Aza-eleven-membered ring compound, preparation method and application thereof, and medicine containing compound | 成都大学 | 2022-05-24 | — | — | CN | disclosed |
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | NEMIS TECHNOLOGIES AG (CH) | 2021-07-15 | — | — | US | disclosed |
| CN-1152906-C | Photoactive polyimides, polyamic acids or esters thereof with pendant photocrosslinkable groups | — | 2004-06-09 | — | — | CN | disclosed |
| WO-2004046354-A1 | OLIGORIBONUCLEOTIDES FOR TREATING DEGENERATIVE SKIN DISORDERS BY RNA INTERFERENCE | BEIERSDORF AG (DE) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004018042-A2 | USE OF ANTISENSE OLIGONUCLEOTIDES FOR TREATING DEGENERATIVE SKIN SYMPTOMS | BEIERSDORF AG (DE) | 2004-03-04 | — | — | WO | disclosed |
| EP-1305003-A2 | USE OF A COMBINATION OF ACTIVE SUBSTANCES CONTAINING BIOQUINONES FOR THE PRODUCTION OF COSMETIC OR DERMATOLOGICAL PREPARATIONS | GS DEVELOPMENT AB (SE) | 2003-05-02 | — | — | EP | disclosed |
| CN-1395593-A | Photoactive polyimides, polyamide acids or esters with side chain photocrosslinkable groups | ROLIC AG (CH) | 2003-02-05 | — | — | CN | disclosed |
| WO-2002009657-A1 | USE OF BIOQUINONES FOR PRODUCING COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR TREATING THE HAIR AND THE SCALP | GS DEVELOPMENT A.B. (SE) | 2002-02-07 | — | — | WO | disclosed |
| WO-2002009664-A2 | USE OF A COMBINATION OF ACTIVE SUBSTANCES CONTAINING BIOQUINONES FOR THE PRODUCTION OF COSMETIC OR DERMATOLOGICAL PREPARATIONS | GS DEVELOPMENT A.B. (SE) | 2002-02-07 | — | — | WO | disclosed |
| US-4368311-A | KETIMINE AND CUPRIC OR FERRIC COMPOUND | PEROXID-CHEMIE GMBH (DE) | 1983-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219907-A1 | CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES | CPA2, RO60, C5AR1 | TSHR 3550/4885THRB 4456/4885FAAH 1426/4885 |
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | VEGFA, GUSB, NR2E3 | TSHR 2913/4885THRB 2211/4885FAAH 2284/4885 |
| US-20240018111-A1 | ALPHA, BETA UNSATURATED METHACRYLIC ESTERS WITH ANTI-INFLAMMATORY PROPERTIES | PTGS1, PTGER1, PTGES2 | TSHR 3299/4885THRB 1165/4885FAAH 189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.